Here’s what you should know:
1. Perceptive Advisors led the financing round, serving as the exclusive investor.
2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn’s disease and ulcerative colitis.
3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.
More articles on gastroenterology:
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes
